Catalent’s new pharmaceutical packaging facility in Shiga, Japan

SOMERSET, N.J. (PRWEB)
July 01, 2020

Catalent, a global leader in clinical supply services, today announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture of Japan.

Operating in partnership with the company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot facility will provide customers with flexible clinical supply solutions, serving both local customers, and global biotech and pharmaceutical companies. The facility will play an important role in Catalent’s expanding Asia-Pacific network, working alongside two sites in China and one in Singapore to ensure customers’ clinical trials are well-served across the region.

The facility will offer extensive clinical supply services including access to Catalent’s FastChain® demand-led supply services, primary and secondary packaging capabilities, a range of temperature options for storage and distribution, as well as clinical returns and destruction services.

For more information on Catalent’s clinical supply capabilities visit https://www.clinical.catalent.com.

About Catalent Clinical Supply Services

Catalent is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. Catalent offers a full range services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine GMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years’ experience across thousands of studies in more than 80 countries, Catalent has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world.

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 13,500 people, including approximately 2,400 scientists and technicians, at more than 40 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

“Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalization, rehospitalization, home health, nursing home, and ED costs.”

NEW YORK (PRWEB)
July 01, 2020

Dexur’s analysis of medicare claims of hospitals within a 25-mile radius of Cleveland, Ohio, showed that University Hospitals Ahuja Medical Center, Southwest General Health Center, and Lutheran Hospital had the best value outcomes over a 90 day episode for Hip & Knee replacement. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. Total cost of care helps patients make appropriate choices and helps local ACOs, such as Cleveland Clinic Medicare ACO, LLC, University Hospitals Coordinated Care Organization, and MetroHealth Care Partners, make appropriate referral choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 470: Major Joint Replacement Or Reattachment Of Lower Extremity Without Major Complication Or Comorbidity (MCC), to adjust for complications and comorbidities.

University Hospitals Ahuja Medical Center’s total cost of care over a 90 day episode was $16,868 (for the period between July 2016 and June 2019). The index hospitalization cost was $11,400 and the average rehospitalization cost per hospitalization was $1,223. The cost per rehospitalization was at an average of $15,768. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $805.

Southwest General Health Center’s total cost of care over a 90 day episode was $16,967 (for the period between July 2016 and June 2019). The index hospitalization cost was $12,263 and the average rehospitalization cost per hospitalization was $1,244. The cost per rehospitalization was at an average of $16,701. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $900.

Lutheran Hospital’s total cost of care over a 90 day episode was $17,089 (for the period between July 2016 and June 2019). The index hospitalization cost was $12,394 and the average rehospitalization cost per hospitalization was $1,089. The cost per rehospitalization was at an average of $14,936. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $664.

Share article on social media or email:

During a system downtime, if our patient needs blood during a surgical procedure, we need immediate access to determine their blood type,” explains the Lead Applications Analyst for the health system.

NATICK, Mass. (PRWEB)
July 01, 2020

Interbit Data, a leading technology company providing care teams with on-demand access to crucial patient data, will host a webinar on Tuesday, July 28, to share how hospitals can retain access to patient information in the event of system downtimes, regardless of their EMR.

Interbit Data’s NetSafe is an automated software solution that ensures uninterrupted, HIPAA-compliant access to patient data during system downtimes, including planned updates, power outages, natural disasters, and cyberattacks.

“System downtimes occur for a multitude of reasons,” says Arthur Young, President and CEO of Interbit Data. “When they do, it’s our job to make sure frontline caregivers still have accurate, secure information at their fingertips to make the real-time treatment decisions that keep patients safe.”

The webinar will highlight a case study from a midwest health system that – once they switched EMRs – could not access critical information for some of their applications and departments, because those applications were not linked with the new EMR. As a result, the health system had no way to access vital blood bank data during system downtimes, a lapse that could compromise patient safety and even risk lives.

“During a system downtime, if our patient needs blood during a surgical procedure, we need immediate access to determine their blood type,” explains the Lead Applications Analyst for the health system.

Hospital and health systems, healthcare IT vendors and members of the media are invited to attend the webinar to discover:

• 
  How to ensure access to data during downtimes
• Why EMR downtime solutions may be insufficient
• How automated report distribution can save crucial time and resources

Webinar: Finally! A Solution to Access Patient Data During Downtimes 

Date: Tuesday, July 28, 2020

Time: 1:00 – 1:45 pm ET

Register Here

About Interbit Data

Interbit Data is an industry leader in data accessibility for hospitals and health systems. Our software solutions ensure secure, reliable access to patient information anytime, anywhere – including at offsite locations, during system downtimes, and even during cyberattacks. With 23+ years in business and more than 700 customers across North America, we are experts at data access and report distribution, empowering you to improve efficiency, streamline workflows, provide optimal patient service and high-quality care, all while meeting federal patient privacy and access requirements. Discover more at interbitdata.com.

Share article on social media or email:

New Terpene Infused Rolling Products

“We’ve made it easier than ever for brands to take powerful, terpene-driven flavors and experiences to global markets, by eliminating their out-of-pocket spend for research, development, and manufacturing,” says Max Koby, Chief Executive Officer of ABSTRAX.

IRVINE, Calif. (PRWEB)
July 01, 2020

ABSTRAX, an industry leader in the study and production of cannabis and botanically-derived terpenes, has officially released its new terpene infused product line including custom rolling papers, cones, flat wraps, and blunts offering brands a way for consumers to enjoy cannabis terpene profiles and flavors worldwide.

“We’ve made it easier than ever for brands to take powerful, terpene-driven flavors and experiences to global markets, by eliminating their out-of-pocket spend for research, development, and manufacturing,” says Max Koby, Founding Partner and Chief Executive Officer of ABSTRAX.

Each offering within the custom terpene infused catalog boasts of ABSTRAX’s one-of-a-kind terpene formulations developed to create unforgettable sensorial experiences and inspire unparalleled “functional” mind/body benefits. They come as a result of the company’s dedication to studying botanicals, including cannabis and hemp, to find the best strain-specific profiles to meet specific brand and consumer desires.

“With cannabis brands, for example, we study every strain profile to discover the unique properties that create the specific flavors and experiences,” says Koby. “This enables us to capture the essence of the plant and recreate this profile using botanically derived ingredients that can be used to enhance the user experience and can be legally distributed around the world. We can then help them develop ‘functional cannabis flavored joint papers’ that completely blow a brand’s target demographic away.”

ABSTRAX’s papers are made of chamomile and yerba mate leaves that are pre-tested in Brazilian laboratories before sourcing. Once the raw material has been approved by the lab, it buys the material in the form of bobbin in the United States. The bobbin is then sent to a laboratory in California for secondary testing. This process assures that all materials are completely safe and approved for consumption in cannabis markets and beyond. Finally, ABSTRAX isolates the bobbin so it has as natural a base as possible to leave room for the aromas and tastes of the botanical terpenes.

These paper and wraps were specifically engineered for infusion with terpenes using the highest quality materials from natural herbal extracts to create a superior smoking experience available in both paper and blunt cones or wraps. Most papers have some type of mild flavoring and ABSTRAX has to create the most natural base materials for both blunt wraps and papers to ensure that each terpene’s infused preroll only has the flavor and characteristics of the intended formulations. In addition, ABSTRAX has partnered with a cigarette manufacturer to create an automated process for safely and consistently infusing the correct dosage of terpenes into papers to create the most effective and consistent experience with uniform appearance.

Cannabis and Hemp brands can work one-on-one with ABSTRAX to develop unique terpene formulations made possible by the company’s science-driven analysis of more than 400 cannabis aroma compounds and development of the 3D metabolite fingerprint™, which allows for botanical terpenes and strain specific terpene blends to be manufactured with unwavering consistency. ABSTRAX works with them to create safe, powerful, and consistent proprietary formulations with specific “functional” benefits and amazing flavor profiles.

“This is only the beginning and yet we’ve come so far. We’re here to serve brands and their customers as they seek to benefit from the all-natural power of terpenes,” says Koby.

About ABSTRAX

Leveraging its proven background in cannabis research, ABSTRAX is the leader in the research, development, and production of botanically-derived and cannabis-inspired terpenes that create unforgettable sensorial experiences. Headquartered in California, the company owns and operates a state-of-the-art type 7 licensed research and manufacturing lab where it’s award-winning product developers and scientists leverage the most advanced strain analysis technology to extract and study aroma compounds via three-dimensional analysis, allowing for each and every compound within a plant to be named and studied. The company has partnered with many of the best cultivators in the industry to study their cannabis profiles and create the world’s most advanced terpene formulations. As a result of its efforts, ABSTRAX offers the largest terpene catalogue of the most popular strains – botanically-derived terpene blends and isolates native to cannabis. These ingredients, also known as functional flavors and aromas, are used in vapes, concentrates, edibles, beer, essential oils, fragrances, cosmetics, topicals, tinctures, alcohol, food and beverage, personal care, and more. The company works with internationally recognized brands and provides unparalleled cannabis research, innovation, and custom formulations to create products that engage and thrill consumers. ABSTRAX also devotes significant resources to developing the highest terpene standards and best practices in the industry. The company has developed a robust quality management system including Gas Chromatography analysis and molecular distillation of natural ingredients to achieve the highest purity standards. Investigating and ensuring that ingredients used in its own products, and products within its industry, are safe for consumption. The terpene industry is a rapidly growing segment of the global flavor and fragrance market, which is expected to grow to $35 billion by 2024. This market segment includes the cannabis, CBD, skincare, cosmetics, health and wellness, food and beverage industries. For more information, visit AbstraxTech.com.

Share article on social media or email:

Christina Smitley, FNP-C with Advanced Dermatology PC

Athlete’s foot – medical name tinea pedis– is very common and affects as many as fifteen percent of the population.

ALBERTSON, N.Y. (PRWEB)
July 01, 2020

Finally! We’re ready to tiptoe through the tulips, across the sand and into the water! But wait! What about our feet? “After a winter’s worth of lousy-weather footwear,” notes Christina Smitley, a board-certified family nurse practitioner specializing in dermatology with Advanced Dermatology PC, “our feet – and especially our toes – may be in need of some seasonal clean-up too.”

“In some cases,” says Smitley, “our toes may simply need a little R and R: perhaps there are calluses that will respond to pumice treatment and moisturizing. Or an ingrown nail that will clear up after soaking and changing to more accommodating footwear.”

But the moist environment of our winter boots can also lead to fungal infections like athlete’s foot: a red, itchy rash that typically shows up between the toes. “Athlete’s foot – medical name tinea pedis– is very common,” observes Smitley. “It affects as many as fifteen percent of the population.”

And fungus can infect our toenails too, causing ‘onychomycosis,’ which discolors and progressively damages the nail. “If we notice a change in a toenail’s appearance, we need to get it checked,” emphasizes Smitley. “We don’t want to try to hide it under polish because infections are harder to treat the longer we have them.”

To help get our feet in shape for the season, as well as happy and healthy all summer long, Smitley makes the following suggestions.

6 Tips to Put Your Best Foot Forward:

1. ‘TLC’ = ‘Toe-Loving Care’: “Out of sight, out of mind? I hope not,” emphasizes Smitley. “Skin care routines such as daily moisturizing must include our feet. In particular, our toes and toenails need special attention, especially if we use drying chemicals like nail-polish remover. For those with calluses or corns, careful use of a pumice stone, followed by moisturizing, will help address the build up.”

2. Nail the basics of nail care: “Preventative nail care will help keep our feet happy and healthy all summer long,” says Smitley, “as well as looking good for walking barefoot. We should trim our nails after bathing or soaking, being careful to cut in an even line. And we need to be extra gentle with our cuticles, which should not be trimmed or shaped. Also, we should regularly disinfect our tools. These steps can prevent infections. If applying polish, consider using an extra base coat under bright oranges and reds to prevent nail discoloration.”

3. Kick the uncomfortable-shoe habit: “Our footwear can cause big problems – even after we’ve taken off the shoes,” observes Smitley. “Calluses and corns are our body’s attempt to protect our feet from tight or poorly fitting footwear. Similarly, excess pressure against the toe can trigger ingrown nails.”

4. Don’t let fungus ruin your fun: “No one wants athlete’s foot or toenail fungus,” notes Smitley. “They’re unsightly and uncomfortable. Nail fungus, in particular, often requires prescription medication or other interventions, like laser treatment. Fungus loves warm, damp environments, so we want to keep our feet cool and dry, by wearing ‘breathable’ footwear, immediately getting out of damp socks, and using drying powders.”

5. Give your salon a checkup: “The coronavirus really highlighted the importance of thoroughly disinfecting surfaces,” states Smitley. “Proper cleaning protocol also prevents bacterial and fungal infections that can be transmitted during spa treatments, like pedicures. If you’re unsure, ask the staff how they disinfect footbaths and nail tools. And if you regularly get your nails done, consider bringing your own tools to your salon.”

6. Keep on your toes for problems that need a doctor: “In some cases, toenail problems need medical attention,” says Smitley. “Pain, redness, or swelling around the nail may be an infection. Changes in the nail such as discoloration, lifting or pitting can be due to a range of systemic conditions, some serious, so they should be evaluated.”

“Regular TLC for our feet,” concludes Smitley, “will help us enjoy that the walk across the sand to the water’s edge – and along all the other the other paths we travel throughout the summer.”

Bio: Christina Smitley, FNP-C, is a family nurse practitioner with Advanced Dermatology pc, and is board-certified through the American Academy of Nurse Practitioners.

Advanced Dermatology P.C. and the Center for Laser and Cosmetic Surgery (New York & New Jersey) is one of the leading dermatology centers in the nation, offering highly experienced physicians in the fields of cosmetic and laser dermatology as well as plastic surgery and state-of-the-art medical technologies. http://www.advanceddermatologypc.com

Share article on social media or email: